Department of Genetics, Physiology, and Microbiology, Faculty of Biology, Complutense University/Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), 28040 Madrid, Spain.
Cardiovascular Joint Research Unit, Francisco de Vitoria University/Hospital Ramon y Cajal Research Unit (IRYCIS), 28223 Madrid, Spain.
Int J Mol Sci. 2018 May 17;19(5):1495. doi: 10.3390/ijms19051495.
Carbamylation is a post-translational modification of proteins that may partake in the oxidative stress-associated cell damage, and its increment has been recently proposed as a "hallmark of aging". The molecular mechanisms associated with aging are related to an increased release of free radicals. We have studied whether carbamylated proteins from the peripheral blood of healthy subjects are related to oxidative damage and aging, taking into account the gender and the immune profile of the subjects. The study was performed in healthy human volunteers. The detection of protein carbamylation and malondialdehyde (MDA) levels was evaluated using commercial kits. The immune profile was calculated using parameters of immune cell function. The results show that the individuals from the elderly group (60⁻79 years old) have increased carbamylated protein and MDA levels. When considered by gender, only men between 60 and 79 years old showed significantly increased carbamylated proteins and MDA levels. When those subjects were classified by their immune profile, the carbamylated protein levels were higher in those with an older immune profile. In conclusion, the carbamylation of proteins in peripheral blood is related to age-associated oxidative damage and to an aging functional immunological signature. Our results suggest that carbamylated proteins may play an important role at the cellular level in the aging process.
氨甲酰化是一种蛋白质的翻译后修饰,可能参与氧化应激相关的细胞损伤,其增加最近被提出作为“衰老的标志”。与衰老相关的分子机制与自由基的释放增加有关。我们研究了健康受试者外周血中的氨甲酰化蛋白是否与氧化损伤和衰老有关,同时考虑了受试者的性别和免疫特征。该研究在健康的人类志愿者中进行。使用商业试剂盒评估蛋白质氨甲酰化和丙二醛 (MDA) 水平的检测。使用免疫细胞功能的参数计算免疫特征。结果表明,老年组(60⁻79 岁)个体的氨甲酰化蛋白和 MDA 水平升高。按性别考虑时,只有 60 至 79 岁的男性显示出明显增加的氨甲酰化蛋白和 MDA 水平。当根据他们的免疫特征对这些受试者进行分类时,具有较老免疫特征的受试者的氨甲酰化蛋白水平更高。总之,外周血中蛋白质的氨甲酰化与年龄相关的氧化损伤以及衰老的功能性免疫特征有关。我们的结果表明,氨甲酰化蛋白可能在衰老过程中在细胞水平上发挥重要作用。